Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q2 2026 · 10-Q
Revenue$2.85B$2.85B+12.7% vs Q2 2025 Net Income$258.00M$258.00M+74.3% vs Q2 2025 EPS Diluted$0.68$0.68+70.0% vs Q2 2025 Operating Income$740,000,000+66.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$593,000,000+212.1% Margins · derivedOperating margin25.9%+8.4 pt vs Q2 2025
Net margin9.0%+3.2 pt vs Q2 2025
ended Jun 30, 2026 · filed Jul 30, 2026 · 30 d after period end